• The number of female gamers is increasing; gender diversity is essential in the board room
• S&P Global reported that firms with female CEOs saw a 20% increase in stock price momentum in the 24 months post-appointment
• CEO Lynn Pearce is highly respected in the gaming industry

Women love to game. Women are a huge part of the gaming industry, accounting for 45% of the US gaming population in 2019 (https://ibn.fm/FNwbu). With the expansion of mobile accessible games and the influx of female pro-gamers on the Esports scene, this number is only increasing. Mobius Interactive. understands the need for gender diversity at every level, from the board room to customer service. Mobius Interactive is proud to call Lynn Pearce their Chief Executive Officer. S&P Global recently ran a study that showed firms with female CEOs saw a 20% increase in stock price momentum in the 24 months post-appointment. Those with high gender diversity on the board of directors saw higher profits than those with low gender diversity (https://ibn.fm/FNzjD). One theory about this success ratio: females in the business world are held to a higher standard. Lynn Pearce co-founded Mobius Interactive. She has served as a vital component of the team since Day One. Her talents are widely-known within the industry: as a regular contributor to Infinity Gaming Magazine and a yearly judge for the prestigious International Gaming Awards, which takes place the evening before the ICE London exhibition. Pearce has extensive senior management experience in online gaming; she has been head-hunted by some of the best in the industry. As a data-driven, commercially focused, strategic marketing leader with over 15 years of success, she has played a critical role in the rapid climb of Mobius Interactive. In Pearce’s recent article, Unicorns in Business Globally (https://ibn.fm/MGBNi), she asks why there are so few female-founded and female-led startups. She points out that fundraising is an essential step at the outset, and that there is a wide gender financing gap in both debt financing and equity financing. A high percentage of female founders have reported experiencing gender discrimination while fundraising. Pearce saw a challenge and tackled it head-on. On the hunt for investors, she was introduced to Gary Eldridge. Gary saw a great opportunity: he joined Pearce in co-founding Mobius Interactive with two other co-founders, Robin Lawson, COO and Nicholas de Freitas, VP Marketing. They set out to create an online Esports entertainment and gaming company that would change the way consumers game worldwide. Since its launch in September 2020, Mobius Interactive has seen continuous month-over-month revenue growth, a conversion rate of new signups above industry standards, and marketing campaigns slated to enter the three biggest iGaming markets in the world (https://ibn.fm/3H3lX). In less than a year, this gender-diverse team, led by CEO Lynn Pearce, has experienced tremendous growth and opportunity. Mobius Interactive is seeking out partnerships and joint-ventures, and plans to take the company public by mid-summer of this year. For more information, visit the company’s website at www.MobiusInteractive.Ltd. NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Sonoma Biologics is committed to having as close to a zero environmental impact as possible and has diversified from premium wine grapes to cannabis
• California weather makes it ideal for growing cannabis outdoors, minimizing the need for climate control and artificial lighting
• The energy required of indoor cannabis factories is positioned to outstrip all California’s wind energy production efforts, even though growing outdoors is 100% viable

Growers across the United States are succumbing to what Evan Mills, a writer for Future Tense, calls the “cannabis carbon trap.” In To Make Cannabis Green, We Need to Grow it Outdoors, Mills highlights the harm that indoor facilities are causing and how outdoor growers, like Sonoma Biologics, are the ones who are doing it right. Sonoma Biologics, an ultra-premium cannabis grower, has committed to having as close to a zero environmental impact as possible. The Company is run by an experienced management team with a proven track record in large-scale agriculture and organic cultivation. Since entering the cannabis industry, Sonoma Biologics has passed stringent California quality control laboratory testing year after year and adhere strictly to organic cultivation methods. “When the cannabis proposition passed in California, we looked at it as another way to diversify what we are doing here on an organic farm,” stated Paul Caracciolo, CEO and Co-founder of Sonoma Biologics (https://ibn.fm/xmce2). “We are very biologically sensitive. And, we’re committed to organics and environmental conservation, for sure.” The California weather makes it ideal for growing cannabis outdoors, minimizing the need for climate control or artificial lighting and lowering the cost of production. Using science as their base, the team at Sonoma Biologics screens and optimizes specific genetic strains to best suit the Sonoma Valley and California climate. Sonoma soil is known for producing exquisite grapes for wine and now is being used, along with the California sunshine, to produce ultra-premium cannabis. Sonoma Biologics is an attractive investment opportunity for those who see the rising value of premium cannabis while also caring about the environmental impact growers have on our irreplaceable earth. “The energy appetite of cannabis factories is already poised to outstrip all California’s wind energy production,” writes Mills. “Can we really afford to allow discretionary indoor cannabis to siphon off clean energy needed for activities that can’t be performed outdoors?” Why, when California’s climate is so prime for cannabis growth, are we wasting precious resources on indoor facilities? Caracciolo believes strongly in using organic to improve lives. As a family business and the place where they live, they have great respect and investment in making the healthiest and most premium product possible. It’s not just a business; for Sonoma Biologics, it’s family. For more information, visit the company’s website at www.OwnSonomaBiologics.com. NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

• Music NFT company BAND Royalty has developed a series of limited edition beautifully curated NFTs in the same vein as HashMasks and CryptoPunks, both of which have had NFTs sell in the millions
• The goal was to give these BAND NFTs a special opportunity to have utility by connecting them to performance royalties of today’s platinum artists such as Beyonce, Jay-Z, Justin Timberlake, Rihanna, Cher, Demi Lovato and so many more
• The first series contains 3,000 NFTs at value ranges between the rare diamond levels (worth 15 to 25 ETH) all pre-sold for $200,000 within 72 hours, to the most widely available vinyl levels (worth 1 ETH)
• A private-buyer presale of the first series sold the three rarest of the NFTs as well as additional other-level NFTs for an Ethereum equivalent of over $700,000 on May 5
• The remainder of the first series’ NFT’s becomes available for public sale directly the Bandroyalty.com website as of May 15
• BAND Royalty buys into seasoned music royalty catalogs and plans on giving BAND NFT holders the opportunity to share in the income generated by these same catalogs once they go through the BAND Royalty staking mechanism

Music entertainment technology company BAND Royalty made a bit of history when it closed its first private presale of a select group of non-fungible tokens (“NFTs”) that not only provide their holders with collectible digital art but also give those  holders an opportunity to share in the song royalties that BAND Royalty owns that are tied to prominent artists’ performances. The BAND NFTs provide digital (blockchain), non-copyright ownership of art-and- the performance royalty selections that feature well-known and popular artists such as Beyoncé, Justin Timberlake, Rihanna, will.i.am, and Jay-Z, and an opportunity to share in the performance royalties generated by the catalog owned by BAND Royalty. The presale round of BAND NFT Series 1 NFT music art collectibles sold the top three Diamond Album BAND NFTs for a combined cryptocurrency value of 60 ETH, which was at the time valued at more than $200,000. In all, the presale round brought in over $700,000 in Ethereum equivalence, according to the company’s news release (https://ibn.fm/DJ8VV). The three diamond-level NFTs were considered to be the most valuable on the market based on their low mint number and rarity — each containing only one exemplar ranging in value from 15 ETH to the double diamond album’s 25 ETH. The three premier NFTs will include Band TOKENS once they are rolled out, and access to all three BAND royalty pools. The royalty pools hope to grant the NFT holder the option of “staking” their NFT art to receive a share of pooled revenues from either printed versions of a musical selection, public and mechanical performances of the musical selection, or visual media synchronization of the selection such as its appearance in a movie, video game or advertisement. Staking involves contractually securing the NFT to a platform for a period of time so that the owner can’t otherwise trade on its value, with the ultimate goal of passively obtaining value from the platform where the NFT is staked, which in BAND’s case involves granting stake holders a share of royalties in the defined pools, if those royalties are ever generated. The period for royalty pool staking ranges from 90 days to five years according to the NFT holder’s wishes and willingness to adopt the risk. The $700,000 value of the total NFT sales included sales of other rarity levels of BAND’s NFT offering below the diamond levels, ranging from vinyl albums (1,500 available, highest mint numbers, worth 1 ETH each) to platinum albums (22 available, lower mint numbers, worth 10 ETH each). The two most valuable platinum levels offer opportunities to stake in all three of the royalty pools, while the three lower value vinyl and gold pools offer a choice of one or two royalty pools to stake in, respectively. With presales completed, the remainder of the 3,000 albums will become available directly from BAND Royalty’s website and NFT marketplace, www.bandroyalty.com, on May 15 for purchase on a first-come, first-served basis. The first series of 3,000 musician NFTs will be followed by three other similar series for an eventual total of 12,000 BAND NFTs. For more information, visit the company’s website at www.BANDRoyalty.com. NOTE TO INVESTORS: The latest news and updates relating to BAND Royalty are available in the company’s newsroom at https://ibn.fm/BAND

• PACR’s partnership with Phenome One gives it access to world’s most exclusive cannabis genetics
• PACR’s genetics-based approach to cultivation resulted in 350 tested cultivars, 50 super-elite strains
• Every ounce of 105,000-pound test run purchased by Speakeasy Cannabis Club
• Company recently acquired established Lords of Grasstown brand that blends cannabis, motorcycle culture

Saturated supply chains and a stream of new market entrants have had little effect on Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian genetics-focused cannabis company dedicated to producing premium strains and products. PACR uses a “genetics first” approach to cultivation that is critical to the company’s success in a market crowded with generic mass-produced cannabis products. Through a partnership with Phenome One, a plant breeding management and analytics firm, PACR has access to a selection of some of the world’s most exclusive cannabis plants from Canada’s most comprehensive genetics library. This allows the company to develop exclusive strains with unique characteristics that include an optimized cannabinoid profile, environmental resiliency, and overall greater production yields. So far, the company’s genetics-based cultivation has produced around 350 tested cultivars that include 50 prized “super-elite” strains that provide maximum yields and increased profitability – a testament to the company’s commitment to produce quality over quantity. Accordingly, the company’s pilot run with joint venture partner Rock Creek Farms produced 105,000 pounds of top-quality biomass – all of which was purchased in one go by the Speakeasy Cannabis Club. “We don’t deal with seeds. It’s different from most hemp farmers where seeds are thrown off of the back of a tractor,” said PacRoots CEO Patrick Elliott Elliot (https://ibn.fm/oWjJf). “We grow these seedlings, clones, clippings or cuttings from a live plant and we grow them for the first month indoors and plant them. What this does is ensure is that you are going to get exactly what you expect out of that cultivar.” Along with producing a superior, differentiated product, PACR leverages the power of iconic branding to connect key audiences with its products. With an eye on the North American West Coast, the Company recently acquired Lords of Grasstown, an established cannabis motorcycle lifestyle brand with a loyal following among biker and cannabis communities (https://ibn.fm/y3HED). Initially founded in 2013, Lords of Grasstown was created to build upon the tremendous success of Lords of Gastown, a lifestyle and apparel brand that fuses motorcycle culture with streetwear and personal care products. “This acquisition marks a major milestone for the company with a move into the U.S. Cannabis Market, predominantly in California, with the Grasstown Brand,” said Elliott. “The team at Lords of Grasstown have done a remarkable job branding, designing, launching and marketing Grasstown in BC and California. The alliances are real, and the followers like what they see. We are thrilled to develop and expand Grasstown from Prince Rupert to San Diego.” Since its inception, Pac Roots has differentiated itself from competitors through its unique genetics-based cultivation approach and branding strategy, allowing it to produce top-shelf products while maximizing yields and minimizing labor costs. As the industry continues to mature, PACR’s long-term multi-pronged strategy gives it a distinct advantage in the highly competitive cannabis market. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• The Union of Musicians and Allied Workers (“UMAW”) has waged war against music streaming companies such as Spotify, demanding that they change their revenue structure to benefit featured artists more
• The Fan Pass platform combines the revenue structure of traditional music streaming sites but with a unique spin, offering artists more opportunities for individual revenue streams
• Friendable has worked hard since launching Fan Pass in 2020 to find ways to increase revenue for artists, including PPV ticket sales, upcoming NFTs, and more

Music streaming companies like Spotify Technology S.A. (NYSE: SPOT) and Apple Inc. (NASDAQ: AAPL) have come under fire recently for not sustaining artist livelihood because the revenue structure they offer does not truly benefit musicians. In the United States, the Union of Musicians and Allied Workers (“UMAW”) was formed to help ensure that musical artists are being paid their fair share of royalties from streaming services. The goal is to create a more just relationship with labels and create safer guidelines for venues. The primary target of the UMAW seems to be Spotify, with the Union demanding:

• Pay of at least one cent per stream
• A user-centric payment model
• Making closed-door contracts available to the public
• Revealing existing payola, then ending it
• Crediting all labor in recordings
• An end to legal battles that are intended to impoverish artists further

A 34-year-old British musician, Nadine Shah, describes her experience as being financially crippled during the pandemic. She is one of the artists who has banded together to force a change. “If we got paid a meaningful income from streaming, that could be a weekly grocery shop; it could contribute to your rent or your mortgage when you need it the most. That’s why I felt compelled to talk about it. I saw so many artists struggling,” Shah said (https://ibn.fm/CuPwg). Under Spotify’s current structure, artists are paid a portion of subscription fees based on the popularity of their music streams. The more popular you are, the higher the potential to earn revenue. Spotify isn’t alone. Many music streaming services utilize the same structure. But Fan Pass, a music streaming platform and application from Friendable (OTC: FDBL), takes the traditional revenue structure and puts its own spin on it. Through the Fan Pass structure, artists earn a portion of the monthly subscription revenue, much like Spotify, but artists who set up ticketed live-streamed events also earn the revenue from their ticket sales. These artists can leverage their fan base for income, not only from monthly subscription revenue, but ticket and merchandise sales as well. Fan Pass was launched at the height of the coronavirus pandemic in July 2020 as a way to enable artists and fans alike to engage in a safe way. “COVID-19 transformed many industries, especially the entertainment/music industry.  Audiences have gravitated toward live stream video through social media, virtual group meetings, and even get-togethers, so fans have been acclimated to consume content digitally.  We’ve made the direct-to-consumer experience an unforgettable, one-of-a-kind experience for both artist and fan,” Friendable CEO Robert A. Rositano Jr. said at the time (https://ibn.fm/7hJJa). He also underlined that Fan Pass is meant to redefine the artist-fan relationship by delivering a unique virtual experience that will be a very lucrative and profitable revenue-sharing model for both the artists and Fan Pass, as fans continue to be invited back for more. The revenue generated by subscriptions and ticket/merchandise sales was only the beginning for the artists on the streaming platform. As recently as April 2021, Friendable has announced expanding the revenue opportunities for artists to include non-fungible tokens (“NFTs”). NFTs represent a unique opportunity for artists and mark the beginning of “Fanpasscrypto.” Each NFT will represent an item such as a photo, video, audio, or another digital-based file. NFTs have generated approximately $237 million in revenue, since 2018, most of it reported in January 2021 (https://ibn.fm/wzRVI). The NFT offering is yet another way in which Fan Pass focuses on empowering artists and helping them increase revenue and elevate their careers through the platform. Fan Pass aims to serve as a true partner to its artist members, who retain full control throughout the entire process and can leverage numerous support tools and services, including marketing materials, logo design and merchandise design services, and more. This approach enables Friendable and Fan Pass to cement their position as a top platform of choice for musicians and fans, as well as a prominent role in the fast-growing global music streaming industry. Before the pandemic, in 2019, the music streaming market was valued at $20.9 billion. The sector is expanding at a CAGR of 17.8 percent, being expected to reach $76.9 billion by 2027 (https://ibn.fm/il8X2). For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• PlantX announced the acquisition of Little West, a California-based producer of ultra-premium cold-pressed juices
• Acquisition to help both companies capitalize on mutual strengths to enhance PlantX’s growth going forward
• The company appears poised to develop a brand portfolio with plans to expand into cosmetics, clothing, and its own water brand.

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant-based, has announced the closing on a previously announced acquisition of Little West LLC (https://ibn.fm/5OzYA). The company had previously announced that it entered into a membership interest purchase agreement through its wholly-owned subsidiary, PlantX Lifestyle USA Inc., to acquire all of the issued and outstanding limited liability membership interest of the acquired company. Little West is a California-based small business founded in 2013 by Cassandra Troy, Andrew Walker, Brad Neumann to produce ultra-premium cold-pressed juices. It soon became a leader in quality standards and fresh taste for cold-pressed fruit beverages. Little West delivers small-batch, cold-pressed juices with no preservatives, concentrates, or added sugars. Every juice contains 2-4 pounds of non-GMO hand-selected and cold-pressed produce that is bottled within 48 hours of harvest for peak freshness, flavor, nutritional value, and health benefits. As such, it appears to be the perfect fit for PlantX’s offering and valuable addition to its brand portfolio. Little West will continue to be run by the founders and their California-based team. The acquisition will allow Little West to leverage PlantX’s superb e-commerce platform, unique technical business expertise, and considerable marketing resources to support Little West’s premier products and accelerate the company’s growth across the U.S. and Canada. The anticipated positive impact of the transaction goes both ways. The Acquisition of Little West will provide PlantX with expertise in the cold-pressed juice segment, which is expected to further support the company’s growth in the North American market. Cold-pressed juices are gaining traction worldwide on the back of increasing health awareness of the growing middle-class consumers. Minimally processed and high-quality products such as organic and natural ingredients are especially in demand. The global market is projected to grow at a CAGR of 6.1% from 2020-2025, with North America as the largest market, followed by Europe, where premiumization is an increasing trend. Committed to eliminating the barriers to entry for consumers seeking to live a plant-based lifestyle and thrive in a longer, healthier and happier life, PlantX carefully chooses additions to its brand portfolio – and Little West appears to be no exception. Notwithstanding huge success and growth, Little West LLC prides itself on remaining true to its community roots and continues to source all fresh produce such as fruits and vegetables from local family farms. The company is devoted to sharing value it derives from its rapid success with the community by donating a part of all profits to Big Green Learning Gardens. It is also committed to giving back to nature by planting one tree for every online order to offset carbon emissions. “It is truly exciting to finalize our acquisition and partnership with Little West,” said Sean Dollinger, PlantX Founder. “We’ve already seen a lot of interest in the Little West cold-pressed juices since we announced our intention to acquire this amazing company, and we are very much looking forward to working together with Little West team and capitalize on our mutual strengths to enhance the company’s growth moving forward.” As the one-stop-shop for everything plant-based, PlantX is poised to leverage its expertise and other valuable resources to capitalize on the combined strengths of the two businesses to secure rapid growth across the North American market. Premium quality cold-pressed juices complement the existing product portfolio that includes more than 10,000 plant-based products offered to customers across North America. The company appears poised to develop further its brand portfolio with plans underway to expand its product lines to include cosmetics, clothing, and its own water brand. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. To visit the company’s YouTube channel, click here. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• In January, Splash Beverage Group acquired Copa Di Vino, leading producer of “wine by the glass” in U.S., immediately creating relationship with Copa Di Vino distributor Pepin Distributing
• Pepin has built distribution empire in Tampa Bay region to include distribution of 168+ premium brands with annual sales of over 10 million cases, 150,000 barrels of national and craft beers, growing wine and spirits portfolio
• Pepin has now added Splash’s SALT naturally flavored 100% Blanco agave tequila line to its product offerings, which will offer considerable exposure to Tampa’s large millennial population

Now that the world has reached a generational inflection point where nearly 80 million millennials outnumber other generations, getting in front of this group’s trends and all their spending power can have a substantive effect on a company’s top and bottom lines. For a spirits company, that’s where having an existing distribution network in a prime millennial region can lead to horizontal growth and a meaningful increase in sales. This month, that’s the exact scenario that played out for Splash Beverage Group (OTCQB: SBEV), as an acquisition was a gateway to get another product into the Tampa, Florida markets. Splash is a portfolio company offering several types of alcoholic and non-alcoholic beverages, ranging from TapouT performance drink to a unique line of naturally flavored tequila. In January, the Fort Lauderdale-based company acquired Copa Di Vino, the leading producer of premium “wine by the glass” in the U.S. With the acquisition came a relationship with Pepin Distributing, a 54-year-old wine and spirits distributor that purveys Copa Di Vino in the greater Tampa Bay region. Since its founding in 1967, Pepin Distributing has seen considerable growth, now employing about 280 people and distributing over 168 premier brands with annual sales that exceed 10 million cases and 150,000 half barrels of Anheuser Busch and other craft beers as well as a growing wine and spirits portfolio. Tampa is a hotbed for millennials, people aged 24-39 by common definitions, as the median age of a Tampa resident is 34.7 years (https://ibn.fm/eNbWN). The ethos of millennials is rooted in experience and variety, an identity lending to the increased popularity of tequila. As noted by ResearchAndMarkets.com (https://ibn.fm/cde6J), “growing demand from millennials is one of the prime reasons driving the tequila market in U.S. growth during the next few years.” Under the new ownership of Splash, it didn’t take long for the relationship with Pepin to expand from only Copa Di Vino to now include Splash’s SALT naturally flavored 100% Blanco agave tequila line. SALT comes in three flavors: berry, citrus and salted chocolate. SALT tequila is grown, distilled, and bottled in the Jalisco region of west-central Mexico. The region is famous for its tequila and is home to George Clooney’s Casamigos Blue Webber agave tequila that was bought by liquor giant Diageo (NYSE: DEO) in 2017 for up to $1 billion. The expanded relationship with Pepin is representative of the model of Splash to make synergistic acquisitions on any number of levels, be it manufacturing, marketing or distribution. “The acquisition of Copa di Vino was a boon for us in a number of ways, and this further proves out our investment model, which is conducive to exponential growth as we continue to expand our sales force and selective acquisitions and/or brand developments,” said Splash President and CMO Bill Meissner. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

• A partnership with Medical Kiwi LTD makes it possible for RYAH to enter the New Zealand Market
• Medical Kiwi was the first South Island-based company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate
• The potential market for medical cannabis in New Zealand is at NZ$1.5 billion

RYAH Group (CSE: RYAH), a health care analytics and technology company, has entered the New Zealand market through a definitive wholesale supply and distribution agreement with Medical Kiwi LTD (https://ibn.fm/jN4T7). This agreement enables RYAH’s suite of IoT devices and cloud-based data analytics to be used in pre-clinical and clinical trial settings and medical patient care alongside Medical Kiwi’s medical cannabis formulations.

“Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner, CEO of RYAH Group Inc. and of RYAH Medtech, Inc.

Medical Kiwi is a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices in New Zealand. The Company has built a strong health-based, scientific and business savvy team. It offers assurance from seed to sale and has built a reputation on innovation, excellence, quality, transparency and service. It was the first South Island-based Company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate.

It is difficult for importers of cannabis to enter the New Zealand market, and many who were once there are pulling out, unable to meet stiff new government standards (https://ibn.fm/J0M4I). Medical Kiwi’s medical cannabis formulations are cultivated, produced, and sold domestically. The analytics that RYAH’s IoT and cloud-based data analytics will help provide the necessary information the country desires in its journey to find safer, more effective medicinal products and better understand the medicinal effects.

RYAH is not the cannabis supplier but instead creates partnerships that enable doctors and patients to personalize plant-based treatments to predict treatment outcomes better. The artificial intelligence platform aggregates and correlates HIPAA-compliant patient data throughout the patient session and formulation lifecycle.

The Ministry of Health estimates that over 250,000 casual cannabis users use it for medicinal purposes, with a potential market estimated at NZ$1.5 billion (https://ibn.fm/7cttP).

“Our new relationship with Medical Kiwi presents an opportunity for both parties to drive innovation and to deliver cutting edge plant-based medical solutions in New Zealand,” stated Wagner.

In addition to the partnership, RYAH and Medical Kiwi are looking to explore the medical device registration of RYAH’s Smart-Inhaler, the first of its kind in New Zealand.

For more information, visit the company’s website at www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

• POAI appoints strategic advisor, venture investor Dr. Christina Jenkins to board of directors
• Dr. Jenkins’ experience spans work in capital markets, clinical medicine, public healthcare systems
• Other roles include current Board Director for Independence Health Group, Venture Partner at Phoenix Venture Partners, Board Observer for Madorra Inc., board advisory roles at multiple value-generating healthcare companies
• Past experience includes role as founding CEO of OneCity Health Services, subsidiary of NYC Health + Hospitals

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently appointed strategic advisor and venture investor Dr. Christina Jenkins to its board of directors.

Dr. Jenkins synergizes capital markets expertise with healthcare industry experience through roles that span clinical medicine, venture capital, healthcare systems and health plans. Her unique set of skills, bolstered by her multivariate perspective and extensive experience, have enabled her to create growth-optimizing strategies for healthcare providers while improving health outcomes for patients.

“We are very fortunate to have Dr. Jenkins join our Board of Directors,” said POAI Chief Executive Officer J. Melville Engle. “As a medical doctor she brings additional insight and perspectives to our team. She has participated and led companies to success in health services and will have an immediate impact at Predictive Oncology and will strengthen our strategic positioning in the market.”

Dr. Jenkins brings extensive experience to POAI through multiple leadership roles across the healthcare space. She is a Board Director for Independence Health Group—the parent organization of Independence Blue Cross and AmeriHealth Caritas—in addition to being a Board Observer for Madorra Inc., a wellness company focused on women’s gynecological health. As a Venture Partner at Phoenix Venture Partners, Dr. Jenkins co-leads the firm’s seed-stage investment strategy in the healthcare/life sciences vertical with a focus on hardware-enabled platform companies that provide innovative ways to diagnose, monitor, and treat health conditions.

Dr. Jenkins’ prior experience includes work as the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals, where she led a team of 130 people in a successful $1.2B effort to design and implement technology-enabled care models and accelerate value-based payment readiness that reduced financial risk for over one million people. In addition to being an advisory board member of multiple value-generating healthcare companies, Dr. Jenkins also leads investment strategies for Portfolia’s FemTech and Active Aging and Longevity funds.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• In 2020, more than 2 billion people purchased goods or services online; e-retail sales surpassed $4.2 trillion worldwide
• New online portal features GPFT’s exclusive line of THC-free, hemp-derived CBD products
• New website allows approved affiliates to sign up to market Hourglass products through their own Grapefruit-approved channels and platforms

According to a recent report from Statista, the retail industry has undergone a transformation, with e-commerce becoming indispensable to a company’s survival (https://ibn.fm/qsJ1U). In that light, the timing appears to be ideal as Grapefruit USA (OTCQB: GPFT) launches its worldwide e-commerce website, www.HourglassOnlineStore.com. The online portal features the company’s exclusive line of THC-free, hemp-derived CBD products powered by its disruptive, patented Hourglass(TM) time-release delivery cream. “Over the last few years, e-commerce has become an indispensable part of the global retail framework,” the Statista report states. “Like many other industries, the retail landscape has undergone a substantial transformation following the advent of the internet, and thanks to the ongoing digitalization of modern life, consumers from virtually every country now profit from the perks of online transactions. As internet access and adoption are rapidly increasing worldwide, the number of digital buyers keeps climbing every year. In 2020, over two billion people purchased goods or services online, and during the same year, e-retail sales surpassed 4.2 trillion U.S. dollars worldwide.” With the launch of its “one-stop shop,” Grapefruit joins the online space, ensuring that people around the world have access to its hallmark THC-free, hemp-derived, Hourglass-powered CBD topical cream; approved affiliate resellers and the company’s online site are the only places where these Grapefruit-manufactured breakthrough Hourglass products are available. “Grapefruit’s new, easy-to-navigate website will allow approved affiliates to sign up to market and sell our THC-free, hemp-derived CBD Hourglass products through their own Grapefruit-approved channels and platforms, which will allow Grapefruit to rapidly increase the availability of our CBD product lines and enhance Hourglass brand awareness,” said Grapefruit CEO Bradley Yourist. “The public will only be able to buy the vastly superior Hourglass-powered, THC-free, hemp-derived Grapefruit CBD products from Grapefruit and/or its authorized agents and affiliate resellers. Only Grapefruit products can provide the significantly superior added bioavailability and time-release properties of the patented Hourglass delivery cream. By analogy, it’s as if Grapefruit was the only company on earth with the right to sell solar panels or electric cars.” Grapefruit has built a stellar reputation for offering only high-quality, tested and reliable products, and has become recognized for its novel delivery system, which differentiates GPFT’s Hourglass products from others in the industry. The delivery system uses patented microsized particles to slowly deliver a wide range of cannabinoids through skin topical administration, solving an ongoing barrier of absorbability. In addition to its highly effective delivery system, Grapefruit offers products that are thoroughly tested and that include a QR-coded Certificate of Analysis. This certificate provides consumers with a complete list of third-party verified ingredients, certifying each product’s cannabinoid content, purity and safety. Looking forward, Grapefruit anticipates its new e-commerce website will be home to its growing portfolio of THC-free, made-in-the-U.S., hemp-derived CBD products; the company also plans to make available on the website all future hemp, CBD-based products featuring its patented bioavailability-increasing, time-release Hourglass topical cream technology. GPFT’s direct-to-consumer e-commerce store was announced earlier this month and went live on time and under budget, Yourist said. “Grapefruit’s entire team is honored to offer both U.S. and international customers a convenient, one-stop shop to purchase our THC-free, hemp-derived CBD Hourglass time-release delivery cream-powered products.” To find out more about the company and its game-changing Hourglass time-release cannabinoid delivery cream, please visit www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT